B. Riley Financial Has Lowered Expectations for Amprius Technologies (NYSE:AMPX) Stock Price

Amprius Technologies (NYSE:AMPX – Get Free Report) had its price target lowered by stock analysts at B. Riley Financial from $22.00 to $16.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. B. Riley Financial‘s price objective would suggest a potential upside of 98.46% from the stock’s current price.

Several other research firms have also recently commented on AMPX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research note on Thursday, October 15th. Needham & Company LLC reduced their price target on Amprius Technologies from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday. Zacks Research raised Amprius Technologies from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. HC Wainwright restated a “buy” rating and set a $18.00 price objective on shares of Amprius Technologies in a report on Tuesday, September 29th. Finally, Canaccord Genuity Group began coverage on Amprius Technologies in a research report on Wednesday, October 14th. They issued a “buy” rating and a $14.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Amprius Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.50.

Read Our Latest Research Report on Amprius Technologies

Amprius Technologies Stock Performance

Shares of NYSE:AMPX opened at $8.06 on Thursday. The stock has a market cap of $1.14 billion, a PE ratio of -28.85 and a beta of 2.36. Amprius Technologies has a one year low of $7.02 and a one year high of $24.23. The business’s fifty day moving average price is $9.06 and its two-hundred day moving average price is $13.21.

Amprius Technologies (NYSE:AMPX – Get Free Report) last posted its quarterly earnings data on Tuesday, November 10th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Amprius Technologies had a negative return on equity of 12.01% and a negative net margin of 29.94%. The company had revenue of $39.15 million for the quarter, compared to analysts’ expectations of $35.80 million. During the same quarter in the prior year, the business posted ($0.03) EPS. As a group, equities research analysts predict that Amprius Technologies will post -0.08 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Thomas M. Stepien sold 23,529 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $10.34, for a total value of $243,289.86. Following the sale, the chief executive officer directly owned 602,096 shares of the company’s stock, valued at approximately $6,225,672.64. This trade represents a 3.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kang Sun sold 62,101 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $10.34, for a total transaction of $642,124.34. Following the completion of the sale, the director owned 1,218,397 shares of the company’s stock, valued at approximately $12,598,224.98. The trade was a 4.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 123,311 shares of company stock valued at $1,272,556 in the last 90 days. 5.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Amprius Technologies

Several institutional investors and hedge funds have recently bought and sold shares of AMPX. Stephens Investment Management Group LLC raised its stake in Amprius Technologies by 517.1% during the third quarter. Stephens Investment Management Group LLC now owns 4,408,140 shares of the company’s stock worth $42,671,000 after purchasing an additional 3,693,816 shares during the period. Sei Investments Co. increased its holdings in shares of Amprius Technologies by 34.1% during the 1st quarter. Sei Investments Co. now owns 579,161 shares of the company’s stock worth $9,765,000 after buying an additional 147,375 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Amprius Technologies by 700.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 431,398 shares of the company’s stock worth $6,695,000 after buying an additional 377,485 shares during the last quarter. First Trust Advisors LP increased its holdings in shares of Amprius Technologies by 1,105.0% during the 1st quarter. First Trust Advisors LP now owns 394,569 shares of the company’s stock worth $6,652,000 after buying an additional 361,825 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Amprius Technologies by 218.7% in the 1st quarter. Renaissance Technologies LLC now owns 359,525 shares of the company’s stock worth $6,062,000 after buying an additional 246,700 shares during the period. Institutional investors and hedge funds own 5.04% of the company’s stock.

Key Amprius Technologies News

Here’s some of the latest news about AMPX:

  • Positive Sentiment: Amprius reported third-quarter revenue of $39.1 million, up 83% year over year and above the $35.8 million analyst estimate. Gross profit also increased, and the company raised its 2026 revenue forecast to $145 million, ahead of the roughly $140.6 million consensus. Amprius third-quarter results
  • Positive Sentiment: The company plans to build U.S. pouch-cell capacity capable of producing 12 million cells annually by early 2028, which could support its growth ambitions if demand and execution materialize. Capacity and revenue outlook
  • Negative Sentiment: Quarterly EPS was a loss of $0.02, missing the $0.01-per-share loss analysts expected. Freight costs weighed on margins, and the earnings shortfall appears to have outweighed the revenue beat in the market’s reaction. Q3 earnings call transcript

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc. develops and manufactures lithium-ion batteries designed to provide high energy density and power. Its battery technology uses silicon-based anodes, an alternative to the graphite anodes commonly used in conventional lithium-ion cells. The company’s products are designed for applications where low weight and high performance are important, including electric aviation, drones, aerospace, defense and other mobility markets. Amprius offers silicon-anode cells for customers developing these systems.

Further Reading

Analyst Recommendations for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.